Stage IIIB Cutaneous Melanoma AJCC v7 Active Not Recruiting Phase 2 Trials for Nivolumab (DB09035)

IndicationStatusPhase
DBCOND0091048 (Stage IIIB Cutaneous Melanoma AJCC v7)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03033576Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced MelanomaTreatment
NCT02519322Neoadjuvant and Adjuvant Checkpoint BlockadeTreatment